A molecular pathway which may impact on the development of schizophrenia has been identified by scientists from St. Jude Children's Research Hospital while they were studying a rare genetic disorder. The researchers, who reported their finding in the October 10th issue of The Journal of Neuroscience, say their discovery might pave the way for a new therapeutic target for treating schizophrenia...